Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis
Year: 2015
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: British Journal of Haematology
DOI: 10.1111/bjh.13463
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Celgene, Pharmacyclics
OpenAlex ID: W2024972915
